Agave Syrup Extract Composition for Anticancer Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current agave syrup extracts lack comprehensive understanding of their antioxidant and anticancer properties, and existing methods do not effectively harness their potential for inhibiting cancer cell growth or providing antioxidant effects.

Innovation Solution

Development of an agave syrup extract composition from Agave spp. varieties like A. atrovirens, A. salmiana, and A. lehmanni, which includes partially purified saponins, phytosterols, polyphenols, flavonoids, and tannins, combined with vitamins A, C, and E, or selenium, for use in food supplements, cosmetics, or medicines to inhibit cancer cell growth and provide antioxidant effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If agave syrup extract is used as an antioxidant or food supplement, then antioxidant properties are provided, but anticancer activity is not fully harnessed

Engineering Contradiction:
Improveanticancer activityVSAvoidextraction method effectiveness
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by optimizing extraction conditions including using 70-95% ethanol as solvent, controlling extraction temperature at 25-40°C, and maintaining extraction time of 2-24 hours. These parameter optimizations maximize the extraction of bioactive compounds (polyphenols, flavonoids, saponins, phytosterols) while preserving their anticancer and antioxidant activities.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by combining multiple extraction methods (maceration, Soxhlet extraction, ultrasound-assisted extraction) and using composite solvent systems (ethanol-water mixtures). The final extract contains a composite of various phytochemicals working synergistically to provide both antioxidant and anticancer effects.

Inventive Principle:
Principle #40Composite materials

2Reliability

If comprehensive phytochemical extraction is performed, then antioxidant and anticancer properties are enhanced, but extraction complexity increases

Engineering Contradiction:
Improvebioactivity effectivenessVSAvoidextraction process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the extraction process into distinct stages: preliminary maceration, main extraction (Soxhlet or ultrasound-assisted), filtration, and concentration. Each stage targets specific phytochemical compounds, allowing comprehensive extraction while maintaining process manageability and reducing overall complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses ethanol-water mixture as an intermediary solvent that facilitates the extraction of diverse phytochemicals with different polarities. This intermediary solvent system enables simultaneous extraction of polyphenols, flavonoids, saponins, and phytosterols without requiring multiple separate extraction processes.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If natural agave compounds are used, then safety and natural origin are maintained, but extraction efficiency and compound concentration are insufficient

Engineering Contradiction:
Improvesafety and natural originVSAvoidextraction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies periodic action through cyclic extraction processes where the solvent is repeatedly passed through the agave material (Soxhlet extraction) or using intermittent ultrasound pulses. This periodic action progressively extracts phytochemicals over multiple cycles, achieving high extraction efficiency while maintaining natural compound integrity and safety.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS9585928B2Agave syrup extract having anticancer activity
Publication Date: 2017.03.07 AGMEL S A DE
  • US9585928B2 patent drawing
  • US9585928B2 patent drawing
  • US9585928B2 patent drawing

AI summary

The present invention comprises an agave extract stored for at least eight weeks, having phytochemicals preferably selected from the group comprising flavonoids, polycosanols and sapogenins, that inhibit cancer cell growth over cells of breast and lymphoma and which provides the agave extract with antioxidant and chemopreventive properties.